Navigation Links
Warner Chilcott to Present at the 29th Annual J.P. Morgan Healthcare Conference
Date:1/4/2011

DUBLIN, Jan. 4, 2011 /PRNewswire/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 2:00 p.m. PST (5:00 p.m. EST).  Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief Executive Officer.

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Warner Chilcott to Present at the Bank of America Merrill Lynch Credit Conference
2. Warner Chilcott Announces FDA Approval of New Oral Contraceptive
3. Warner Chilcott Completes Acquisition of U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
4. Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
5. TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic
6. Warner Chilcott Announces FDA Approval of Next Generation Actonel
7. Warner Chilcott Announces the Closing of its $500 Million Senior Notes Offering
8. Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex®
9. Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
10. Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex®
11. Warner Chilcott to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition ... report to their offering. ... The ablation device global market is expected to ... 2023. Ablation is the minimally invasive therapeutic tissue ... or diseased tissue removal, to the removal of abnormally conducting cardiac ...
(Date:3/29/2017)... , March 29, 2017   Dynatronics ... today the appointment of Cynthia L. McHenry ... will be responsible for leading Dynatronics manufacturing, distribution, ... will report to Dynatronics, CEO Kelvyn H. ... concludes an extensive search process conducted by the ...
(Date:3/29/2017)... 29, 2017 FinancialBuzz.com News Commentary  ... Data published in a research report by Grand ... a value of USD 55.8 billion by 2025. The projection takes into ... and a more open approach towards cannabis products around the ... Florida , North Dakota , Ohio ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million ... only option for on-premises installation of its Help System for SharePoint was at the ... system into the entire tenant. , The company recently released a modified version ...
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... Rochester, MN (PRWEB) , ... March 28, 2017 ... ... Elastography (MRE), is pleased to be invited to the Siemens Healthineers annual ... imaging professionals. The event will take place from March 27 - 31, ...
(Date:3/28/2017)... ... March 29, 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one of ... series titled The Thyroid Secret. Dr. Wentz talked about journey and research recently on ... that medication IS NOT the only solution to deal with thyroid disease. , ...
(Date:3/28/2017)... San Mateo, CA (PRWEB) , ... ... ... Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science ... manuscript leveraging data from its RSSearch Patient Registry, a multi-institutional, observational registry ...
Breaking Medicine News(10 mins):